Medical Sales Representative

Information Circular No. 185/CD/8.1.6 of 31/07/2013

Establishing rules and procedures for the registration of the visits to the establishments and NHS services by the medical sales representatives.

Pharmacovigilance

Information Circular No. 206/CD/8.1.6 of 09/06/2013

Informs the Marketing Authorization Holders that whenever changes are detected to the risk-benefit ratio, new risks or change of the known risks of medicinal products, with implications for public health, should be reported immediately to Infarmed.